Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny

References

• Rizzo JD, Wingard JR, Tichelli A, et al Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006;12:138–151.
   PubMed Web of Science ®Google Scholar
• De Medeiros BC, de Medeiros CR, Werner B, et al Disseminated toxoplasmosis after bone marrow transplantation: report of 9 cases. Transpl Infect Dis 2001;3:24–28.
   PubMedGoogle Scholar
• Krüger WH, Bohlius J, Cornely OA, et al Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the German society of haematology and oncology. Ann Oncol 2005;16:1381–1390.
   PubMed Web of Science ®Google Scholar
• Pagano L, Fianchi L, Mele L, et al Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres. Br J Haematol 2002;117:370–386.
   Web of Science ®Google Scholar
• Daly A, McAfee S, Dey B, et al Nonmyeloablative bone marrow transplantation: infectious complications in 65 recipients of HLA-identical and mismatched transplants. Biol Blood Marrow Transplant 2003;9:373–382.
   PubMed Web of Science ®Google Scholar
• Marras TK, Sanders K, Lipton JH, Messner HA, Conly J, Chan CK. Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation. Transpl Infect Dis 2002;4:66–74.
   PubMedGoogle Scholar
• Vasconcelles MJ, Bernardo MV, King C, Weller EA, Antin JH. Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. Biol Blood Marrow Transplant 2000;6:35–43.
   PubMed Web of Science ®Google Scholar
• Martino R, Bretagne S, Einsele H, et al Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 2005;40:67–68.
   PubMed Web of Science ®Google Scholar
• Fricker-Hidalgo H, Bulabois C, Brenier-Pinchart et al Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques. Clin Infect Dis 2009;48:e9–e15.
   PubMed Web of Science ®Google Scholar
• Slavin MA, Meyers JD, Remington JS, Hackman RC. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994;13:549–557.
   PubMed Web of Science ®Google Scholar
• Martino R, Maertens J, Bretagne S, et al Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 2000;31:1888–1894.
   Google Scholar
• Chandrasekar PH, Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team. Bone Marrow Transplant 1997;19:685–689.
   PubMed Web of Science ®Google Scholar
• Small TN, Leung L, Stiles J, et al Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation. Bone Marrow Transplant 2000;25:969–973.
   PubMed Web of Science ®Google Scholar
• Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363:1965–1975.
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Takeishi S, Miyamoto T, et al Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group. Eur J Hematol 2007;79:317–321.
   PubMed Web of Science ®Google Scholar
• Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant 2002;29:691–698.
   PubMed Web of Science ®Google Scholar
• Mueller-Mang C, Mang TG, Kalhs P, Thurnher MM. Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature. Neuroradiology 2006;48:84–89.
   PubMed Web of Science ®Google Scholar
• Friedrich R, Simon HU, Müller WA, Sych FJ. Ocular toxoplasmosis: the role of cellular immune defense in the development of recurrences. Results from animal experiments. Ger J Ophthalmol 1992;1:54–57.
   PubMedGoogle Scholar
• Atmaca LS, Simsek T, Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol 2004;48:386–391.
   PubMed Web of Science ®Google Scholar
• De Smet MD. Differential diagnosis of retinitis and choroiditis in patients with acquired immunodeficiency syndrome. Am J Med 1992;92:17S–21S.
   PubMed Web of Science ®Google Scholar
• Pleyer U, Torun N, Liesenfeld O. Ocular toxoplasmosis. Rev Ophthalmol 2007;104:603–615.
   PubMed Web of Science ®Google Scholar
• Bonfioli AA, Orefice F. Toxoplasmosis. Semin Ophthalmol 2005;20: 29–141.
   Google Scholar
• Montoya JG, Parmley S, Liesenfeld O, Jaffe GJ, Remington JS. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. Ophthalmology 1999;106:1554–1563.
   PubMed Web of Science ®Google Scholar
• Westeneng AC, Rothova A, de Boer JH, de Groot-Mijnes JD. Infectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysis. Am J Ophthalmol 2007;144:781–785.
   PubMed Web of Science ®Google Scholar
• Dabil H, Boley ML, Schmitz TM, Van Gelder RN. Validation of a diagnostic multiplex polymerase chain reaction assay for infectious posterior uveitis. Arch Ophthalmol 2001;119:1315–1322.
   PubMed Web of Science ®Google Scholar
• Janitschke K, Held T, Krüiger D, Schwerdtfeger R, Schlier G, Liesenfeld O. Diagnostic value of tests for Toxoplasma gondii-specific antibodies in patients undergoing bone marrow transplantation. Clin Lab 2003;49:239–242.
   PubMedGoogle Scholar
• Kupferschmidt O, Krüger D, Held TK, Ellerbrok H, Siegert W, Janitschke K. Quantitative detection of Toxoplasma gondii DNA in human body fluids by TaqMan polymerase chain reaction. Clin Microbiol Infect 2001;7:120–124.
   PubMed Web of Science ®Google Scholar
• Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 2008;14:1089–1101.
   PubMed Web of Science ®Google Scholar
• Ionita C, Wasay M, Balos L, Bakshi R. MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease. AJNR Am J Neuroradiol 2004;25:270–273.
   PubMed Web of Science ®Google Scholar
• Fung HB, Kirschenbaum HL. Treatment regimens for patients with toxoplasmic encephalitis. Clin Ther 1996;18:1037–1056.
   PubMed Web of Science ®Google Scholar
• Roemer E, Blau IW, Basara N, et al Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. Clin Infect Dis 2001;32: E1–E8.
   PubMed Web of Science ®Google Scholar
• Schmid C, Schleuning M, Schwerdtfeger R, et al Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. Blood 2006;108:1092–1099.
   PubMed Web of Science ®Google Scholar
• Greven CM, Teot LA. Cytologic identification of Toxoplasma gondii from vitreous fluid. Arch Ophthalmol 1994;112:1086–1088.
   PubMed Web of Science ®Google Scholar
• Rothova A, de Boer JH, Ten Dam-van Loon NH, et al Usefulness of aqueous humor analysis for the diagnosis of posterior uveitis. Ophthalmology 2008;115:306–311.
   PubMed Web of Science ®Google Scholar
• Contini C, Fainardi E, Cultrera R, et al Advanced laboratory techniques for diagnosing Toxoplasma gondii encephalitis in AIDS patients: significance of intrathecal production and comparison with PCR and ECL-western blotting. J Neuroimmunol 1998;92:29–37.
   PubMed Web of Science ®Google Scholar
• Nicolas X, Granier H, Laborde JP, et al Danger of malaria self-treatment. Acute neurologic toxicity of mefloquine and its combination with pyrimethamine-sulfadoxine. Presse Med 2001;30:1349–1350.
   PubMed Web of Science ®Google Scholar
• Al Kadi HO. Antimalarial drug toxicity: a review. Chemotherapy 2007;53:385–391.
   PubMed Web of Science ®Google Scholar
• Fernandez-Martin J, Leport C, Morlat P, Meyohas MC, Chauvin JP, Vilde JL. Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS. Antimicrob Agents Chemother 1991;35:2049–2052.
   PubMed Web of Science ®Google Scholar
• Yuh WT, Nguyen HD, Gao F, Tali ET, et al Brain parenchymal infection in bone marrow transplantation patients: CT and MR findings. AJR Am J Roentgenol 1994;162:425–430.
   PubMed Web of Science ®Google Scholar
• Madden RM, Pui CH, Hughes WT, Flynn PM, Leung W. Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia. Cancer 2007;109:1654–1658.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev 2004;17:770–782.
   PubMed Web of Science ®Google Scholar
• Groll AH, Ritter J, Müller FM. Guidelines for prevention of Pneumocystis carinii pneumonitis in children and adolescents with cancer. Klin Padiatr 2001;213:A38–A49.
   PubMed Web of Science ®Google Scholar